chr10-102604895-G-C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016169.4(SUFU):c.1022+5351G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 26) 
Consequence
 SUFU
NM_016169.4 intron
NM_016169.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.82  
Publications
14 publications found 
Genes affected
 SUFU  (HGNC:16466):  (SUFU negative regulator of hedgehog signaling) The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010] 
SUFU Gene-Disease associations (from GenCC):
- medulloblastomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- nevoid basal cell carcinoma syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina, Genomics England PanelApp
- basal cell nevus syndrome 2Inheritance: AD Classification: STRONG Submitted by: G2P
- ocular motor apraxia, Cogan typeInheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
- Joubert syndrome 32Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Joubert syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- apraxiaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- ciliopathyInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SUFU | ENST00000369902.8 | c.1022+5351G>C | intron_variant | Intron 8 of 11 | 1 | NM_016169.4 | ENSP00000358918.4 | |||
| SUFU | ENST00000423559.2 | c.1022+5351G>C | intron_variant | Intron 8 of 9 | 1 | ENSP00000411597.2 | ||||
| SUFU | ENST00000369899.6 | c.1022+5351G>C | intron_variant | Intron 8 of 10 | 1 | ENSP00000358915.2 | 
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
26
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
26
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.